Management of Prelabor Rupture of the Membranes at Term

NARecruitingINTERVENTIONAL

Enrollment

524

Participants

Timeline

Start Date

May 1, 2020

Primary Completion Date

May 1, 2024

Study Completion Date

May 1, 2024

Conditions

Fetal InfectionChorioamnionitisEndometritisCesarean Section Complications

Interventions

DRUG

Oxytocin

The drug wil be adminisrate for augmentation of labor at admission.

Trial Locations (1)

RECRUITING

Rambam, Ramat Yishai

All Listed Sponsors

lead

Rambam Health Care Campus

OTHER